aztreonam has been researched along with ro13-9904 in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (29.73) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 6 (16.22) | 2.80 |
| Authors | Studies |
|---|---|
| Hannecart-Pokorni, E; Nulens, E; Nyssen, HJ; Vanhoof, R | 1 |
| Bhutta, ZA; Farooqui, BJ; Naqvi, SH | 1 |
| Keller, N; Overbeek, BP; Raponi, G; Rozenberg-Arska, M; Torensma, R; Verhoef, J | 1 |
| Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
| Baykal, M; Hasçelik, G | 1 |
| Avlamis, A; Giamarellou, H; Grammatikou, M; Papoulias, G; Pephanis, A | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Cornaglia, G; Foddis, G; Pompei, R; Satta, G | 1 |
| Cocuzza, CE; Mattina, R; Raimondi, A | 1 |
| Bucaneve, G; Del Favero, A; Guerciolini, R; Menichetti, F; Minotti, V; Patoia, L; Pauluzzi, S | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Bosso, JA; Marble, DA; Townsend, RJ | 1 |
| Barclay, CA; Casellas, JM; Goldberg, M; Iribarren, MA; Traballi, CA | 1 |
| Kohl, I; Then, RL | 1 |
| Aber, RC; Appelbaum, PC; Pankuch, GA; Tamim, J | 1 |
| LeBel, M; Lewis, GP; Paone, RP | 1 |
| Luzzaro, F; Pagani, L; Porta, F; Romero, E | 1 |
| Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
| Alsina, J; Castelao, AM; Cruzado, JM; Gilvernet, S; Grinyó, JM; Riera, L; Serón, D; Soto, K; Torras, J | 1 |
| Dubus, A; Kania, M; Normark, S; Page, MG | 1 |
| Descheemaeker, P; Goossens, H; Ieven, M; Sanders, CC; Vercauteren, E | 1 |
| Coudron, PE; Moland, ES; Sanders, CC | 1 |
| Baadran, I; Dajani, N; Mahafzah, A; Qadar, FA; Shehabi, AA | 1 |
| Arlet, G; Donay, L; Herrmann, J; Lagrange, PH; Nadjar, D; Philippon, A; Rouveau, M; Verdet, C | 1 |
| Canton, R; Casellas, JM; Legakis, N; Winokur, PL | 1 |
| Caprino, L; Togna, AR; Togna, GI | 1 |
| Akasaka, S; Inatomi, H; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
| Baek, YW; Chang, CL; Chong, Y; Chung, HK; Hwang, HY; Jeong, SH; Kim, JM; Kim, WM; Ku, JY; Lee, K; Woo, IG | 1 |
| Alves Filho, JC; Cunha, FQ; D'Avila, LC; da Cunha, AA; de Oliveira, JR; Dias, FS; Leite, CE; Lunardelli, A; Machado, DP; Nunes, FB; Poli de Figueiredo, CE; Poloni, JA; Ruschel, RE; Saciura, VC; Simões Pires, MG | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C | 1 |
| Barbee, LA; Golden, MR | 1 |
| Li, X; Liu, D; Liu, X; Song, L; Xu, Y; Yu, Z; Zhou, T | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Barbee, LA; Golden, MR; LeClair, A; Ocbamichael, N; Soge, OO | 1 |
| Al Atbee, MYN; Jalil, MB | 1 |
| El-Sakhawy, MA | 1 |
1 review(s) available for aztreonam and ro13-9904
| Article | Year |
|---|---|
Aztreonam for Neisseria gonorrhoeae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Gonorrhea; Humans; Neisseria gonorrhoeae | 2020 |
3 trial(s) available for aztreonam and ro13-9904
| Article | Year |
|---|---|
Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
Topics: Agranulocytosis; Aztreonam; Bacterial Infections; Cefazolin; Ceftriaxone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Neoplasms | 1987 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Prophylaxis of urinary tract infection in renal transplantation: comparison of three different protocols using ceftriaxone-cloxacillin, aztreonam-cloxacillin, or aztreonam-amoxycillin-clavulanic acid.
Topics: Adult; Amoxicillin; Aztreonam; Ceftriaxone; Cloxacillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Histocompatibility Testing; Humans; Kidney Transplantation; Male; Postoperative Complications; Urinary Tract Infections | 1995 |
33 other study(ies) available for aztreonam and ro13-9904
| Article | Year |
|---|---|
Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Microbial Sensitivity Tests; Species Specificity | 1992 |
Therapy of multidrug resistant typhoid in 58 children.
Topics: Adolescent; Ampicillin Resistance; Aztreonam; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Ofloxacin; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Blood Bactericidal Activity; Ceftriaxone; Ciprofloxacin; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli; Escherichia coli Infections; Female; Immunization; Immunoglobulin G; Immunoglobulin M; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Netilmicin; Opsonin Proteins; Phagocytosis | 1991 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
[In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
Topics: Aztreonam; Cefoperazone; Ceftriaxone; Gram-Negative Bacteria | 1990 |
In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
Topics: Aztreonam; Ceftriaxone; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Monobactams | 1989 |
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins | 1987 |
Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Escherichia coli; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae | 1988 |
Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Ceftazidime; Ceftriaxone; Cephamycins; Drug Stability; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1988 |
Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
Topics: Aztreonam; Ceftriaxone; Escherichia coli; Humans; Ofloxacin; Oxazines; Phagocytes; Phagocytosis; Rifampin; Serratia marcescens | 1986 |
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Topics: Aztreonam; Ceftazidime; Ceftriaxone; Clindamycin; Drug Stability; Hydrogen-Ion Concentration; Injections, Intravenous; Piperacillin; Solutions; Temperature | 1986 |
Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Microbial Sensitivity Tests; Regression Analysis | 1987 |
Affinity of carumonam for penicillin-binding proteins.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Binding, Competitive; Carboxypeptidases; Carrier Proteins; Cefotaxime; Ceftriaxone; Electrophoresis, Polyacrylamide Gel; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Topics: Acinetobacter; Alcaligenes; Anti-Bacterial Agents; Aztreonam; Bordetella; Cefamandole; Cefotaxime; Cefoxitin; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Aerobic Bacteria; Moraxella; Pseudomonas | 1983 |
Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
Topics: Anti-Bacterial Agents; Autoanalysis; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Creatinine; Humans; Male | 1983 |
Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Humans; Isoelectric Focusing; Monobactams; Plasmids; Serratia marcescens | 1995 |
The role of tyrosine 150 in catalysis of beta-lactam hydrolysis by AmpC beta-lactamase from Escherichia coli investigated by site-directed mutagenesis.
Topics: Acylation; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Catalysis; Ceftriaxone; Cephalothin; Circular Dichroism; Enzyme Stability; Escherichia coli; Hydrolysis; Kinetics; Methicillin; Mutagenesis, Site-Directed; Plasmids; Protein Structure, Secondary; Restriction Mapping; Structure-Activity Relationship; Tyrosine | 1994 |
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
Topics: Aztreonam; beta-Lactamases; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; False Positive Reactions; Klebsiella; Microbial Sensitivity Tests; Monobactams; Sensitivity and Specificity | 1997 |
Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefpodoxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Enterobacteriaceae; Hospitals, Veterans; Isoelectric Focusing; Microbial Sensitivity Tests; Species Specificity; Substrate Specificity | 1997 |
High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units.
Topics: Aztreonam; beta-Lactam Resistance; Cefotaxime; Ceftazidime; Ceftriaxone; Cross Infection; Gram-Negative Bacteria; Humans; Incidence; Intensive Care Units; Jordan; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Prospective Studies; Sensitivity and Specificity | 2000 |
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Hafnia; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Plasmids; Polymerase Chain Reaction | 2000 |
Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.
Topics: Asia, Eastern; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Escherichia coli; Europe; Klebsiella pneumoniae; Latin America; Microbial Sensitivity Tests; North America; Phenotype; Proteus mirabilis; Ribotyping; Salmonella | 2001 |
Beta-lactam antibiotic-mediated changes in platelet reactivity and vascular endothelial functions.
Topics: Adenosine Diphosphate; Animals; Anti-Bacterial Agents; Aorta, Thoracic; Apyrase; Arachidonic Acid; Aztreonam; Blood Platelets; Cattle; Ceftazidime; Ceftriaxone; Collagen; Endothelium, Vascular; Epoprostenol; Humans; In Vitro Techniques; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Time Factors; Tissue Plasminogen Activator | 2001 |
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
Topics: Adult; Anti-Infective Agents; Aztreonam; Cefdinir; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Neisseria gonorrhoeae; Roxithromycin; Spectinomycin; Urethritis | 2001 |
Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.
Topics: Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftriaxone; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction | 2001 |
Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats.
Topics: Animals; Arginine; Ascitic Fluid; Aztreonam; beta-Lactams; Ceftriaxone; Drug Therapy, Combination; Interleukin-10; Interleukin-1beta; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prospective Studies; Young Adult | 2016 |
Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
Topics: Adult; Asian People; Aztreonam; Biological Transport; Ceftazidime; Ceftriaxone; Cefuroxime; Female; Fluconazole; Humans; Imipenem; Kidney; Male; Middle Aged; Models, Biological; Pregnancy; White People; Young Adult | 2020 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Single-Arm Open-Label Clinical Trial of Two Grams of Aztreonam for the Treatment of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Urethritis | 2020 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Combinational Effect of Selected Medicinal Plants and Antibiotics Against Pathogenic Bacteria.
Topics: Anti-Bacterial Agents; Aztreonam; Bacillus cereus; Ceftriaxone; Escherichia coli; Nalidixic Acid; Novobiocin; Plant Extracts; Plants, Medicinal; Staphylococcus aureus | 2023 |